LION - フィデリティ・サザン （Fidelity Southern Corporation） フィデリティ・サザンLIONのチャート
LIONの企業情報
| symbol | LION |
|---|---|
| 会社名 | Fidelity Southern Corp （フィデリティ・サザン） |
| 分野（sector） | Finance 金融 |
| 産業（industry） | Major Banks |
| 業種 | 銀行 金融（Financials） |
| 概要 | 事業概要 フィデリティ・サザン（Fidelity Southern Corporation）は銀行持株銀行である。同社は子会社である州の認可銀行Fidelity Bank (同行)を通して業務を運営する。同社はアトランタおよびフロリダ州ジャクソンビル、オーランドおよびサラソタ・ブレーデントンの大都市圏および商業地域の小売顧客向けに金融商品およびサービスを提供する。同社は住宅ローン、間接的自動車ローン、南部および中西部地域全体にわたるスモールビジネスアドミニストレーション（SBA）ローンを提供している。同社は南部の州にあるオフィスのネットワークを通じて製品とサービスを提供する。同社は個人および企業からの預金を引き受け、これらの預金および借入金を使用して、商業用、住宅用モーゲージ、建設および割賦貸付を提供する。 フィデリティ・サザンは、米国の銀行持株会社。子会社を通じて、個人・企業からの預金と借入れによる資金を元に、ロ―ンを提供する。法人・個人向けクレジットカ―ドロ―ン、インタ―ネットバンキング、インタ―ネットキャッシュマネジメントサ―ビス、リモ―ト預金サ―ビス、国際取引サ―ビス、信託業務、マ―チャントサ―ビス、投資サ―ビスを提供する。 |
| 本社所在地 | 3490 Piedmont Road Suite 1550 Atlanta GA 30305 USA |
| 代表者氏名 | James B. Miller ジェームズB.ミラー |
| 代表者役職名 | Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者 |
| 電話番号 | +1 404-371-5500 |
| 設立年月日 | 29068 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 1394人 |
| url | www.FidelitySouthern.com |
| nasdaq_url | https://www.nasdaq.com/symbol/lion |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 66.31600 |
| 終値（lastsale） | 23.93 |
| 時価総額（marketcap） | 651237863.98 |
| 時価総額 | 時価総額（百万ドル） 652.05430 |
| 売上高 | 売上高（百万ドル） 167.06000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 982.14430 |
| 当期純利益 | 当期純利益（百万ドル） 36.63100 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Fidelity Southern Corporation interest income increased 12% to $86.3M. Net interest income after loan loss provision increased 6% to $66.8M. Net income increased 9% to $21.2M. Net interest income after loan loss provision reflects Net Interest Margin Total - % increase of 2% to 3.26% Loans including fees increase of 12% to $82.7M Taxable interest income increase of 4% to $2.4M. |
LIONのテクニカル分析
LIONのニュース
BIDU, JKS and BILI are among pre market gainers 2023/03/01 13:26:32 Seeking Alpha
Reata Pharmaceuticals (RETA) +175% Pharmaceuticals up 192% on Friedreich''s ataxia drug omaveloxolone approval.OncoSec Medical (ONCS) +94%. Lionheart III (LION) +53%
LION Stock Soars Ahead of Security Matters SPAC Merger 2023/02/23 21:03:56 InvestorPlace
Source: Dmitry Demidovich/ShutterStock.com The world of special purpose acquisition companies (SPACs) is about to get an exciting new member. Blank-check company Lionheart III Corp (NASDAQ: LION ) is rising today as momentum builds for its merger with Australia-based security software solutions company Security Matters . LION stock surged earlier today and, although it has since lost some momentum, shares remain firmly in the green. As of this writing, LION stock is up more than 10% for the day. Meanwhile, SMX — Security Matters’ stock ticker on the Australian Securities Exchange — is up 14%, having enjoyed a day of steady growth. Clearly, the market is eagerly anticipating the successful SPAC merger of this company. Does this mean that LION will continue to rise as investors wait for further merger updates? Let’s take a closer look at the market today and assess the forces pushing up shares. What’s Happening With LION Stock? What’s important to remember is that Lionheart’s successful merger agreement isn’t breaking news.
Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket 2023/02/01 12:55:16 Benzinga
Gainers Motorsport Games Inc. (NASDAQ: MSGM ) shares rose 121% to $47.48 in pre-market trading after jumping over 710% on Tuesday. The company announced a debt-for-equity exchange with Motorsport Network. Also, Investor Mike Zoi reported purchase of 338,983 shares of Motorsport Games at an average price of $2.95 per share in Form 4 Filing. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX ) shares rose 67% to $2.77 in pre-market trading after gaining around 10% on Tuesday. TransCode Therapeutics, Inc. (NASDAQ: RNAZ ) rose 42.5% to $1.07 in pre-market trading after the company reported preclinical results with immunotherapy candidate TTX-RIGA in melanoma. Wearable Devices Ltd. (NASDAQ: WLDS ) shares rose 39.2% to $1.10 in pre-market trading after gaining around 20% on Tuesday. Genetic Technologies Limited (NASDAQ: GENE ) rose 35.2% to $1.23 in pre-market trading. Genetic Technologies is forming strategic alliance with Qiagen, Reuters reported. Lionheart III Corp (NASDAQ: LION ) rose 30.2% to $13.50 in pre-market trading after dropping over 10% on Tuesday.